Terms: = Uterine cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
99 results:
1. Mutation analysis of the tert gene in ovarian cancer patients of the Turkish population by next generation sequencing method.
Capar Gorali B; Gulec Yılmaz S; Akdeniz FT; Attar R; İsbir T
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):51-55. PubMed ID: 38015541
[TBL] [Abstract] [Full Text] [Related]
2. tert promoter mutations and gene amplification in endometrial cancer.
Praiss AM; Marra A; Zhou Q; Rios-Doria E; Momeni-Boroujeni A; Iasonos A; Selenica P; Brown DN; Aghajanian C; Abu-Rustum NR; Ellenson LH; Weigelt B
Gynecol Oncol; 2023 Dec; 179():16-23. PubMed ID: 37890416
[TBL] [Abstract] [Full Text] [Related]
3. COL1A1::PDGFB fusion uterine sarcoma with a tert promoter mutation.
Lu Y; Chen X; Zeng W; Hua P; Shen Y; Qiu Y; He X; Zhang H
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23210. PubMed ID: 37870859
[TBL] [Abstract] [Full Text] [Related]
4. Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.
Liang Y; Ruan H; Yu M; Lü B
Pathology; 2023 Dec; 55(7):966-973. PubMed ID: 37739924
[TBL] [Abstract] [Full Text] [Related]
5. The Comparative Invasiveness of Endometriotic Cell Lines to Breast and Endometrial cancer Cell Lines.
Ellis K; Wood R
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371583
[TBL] [Abstract] [Full Text] [Related]
6. Synthesis, in vitro cytotoxic activity and molecular docking study of androstene and estrone derivatives.
Mistry S; Thakkar M; Singh AK; Patel D
Steroids; 2023 Sep; 197():109259. PubMed ID: 37336339
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of the telomerase holoenzyme induces EMT and tumorigenesis of HPV-immortalized keratinocytes.
Wang A; Zhou D; Krawczyk E; Li T; Simic V; Lu J; Liu X; Schlegel R; Yuan H
J Med Virol; 2023 Apr; 95(4):e28681. PubMed ID: 36929719
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The cancer Genome Atlas-like Prognostic Subgroups.
Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
[TBL] [Abstract] [Full Text] [Related]
9. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors.
Jeremie G; Allias F; Trecourt A; Gaillot-Durand L; Bolze PA; Descotes F; Tondeur G; Perrot J; Hajri T; You B; Golfier F; Lopez J; Devouassoux-Shisheboran M
Mod Pathol; 2023 Jan; 36(1):100046. PubMed ID: 36788063
[TBL] [Abstract] [Full Text] [Related]
11. Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.
Liu J; Li Z; Lu T; Pan J; Li L; Song Y; Hu D; Zhuo Y; Chen Y; Xu Q
BMC Med Genomics; 2022 Nov; 15(1):231. PubMed ID: 36333792
[TBL] [Abstract] [Full Text] [Related]
12. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
[TBL] [Abstract] [Full Text] [Related]
13. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Nacev BA; Sanchez-Vega F; Smith SA; Antonescu CR; Rosenbaum E; Shi H; Tang C; Socci ND; Rana S; Gularte-Mérida R; Zehir A; Gounder MM; Bowler TG; Luthra A; Jadeja B; Okada A; Strong JA; Stoller J; Chan JE; Chi P; D'Angelo SP; Dickson MA; Kelly CM; Keohan ML; Movva S; Thornton K; Meyers PA; Wexler LH; Slotkin EK; Glade Bender JL; Shukla NN; Hensley ML; Healey JH; La Quaglia MP; Alektiar KM; Crago AM; Yoon SS; Untch BR; Chiang S; Agaram NP; Hameed MR; Berger MF; Solit DB; Schultz N; Ladanyi M; Singer S; Tap WD
Nat Commun; 2022 Jun; 13(1):3405. PubMed ID: 35705560
[TBL] [Abstract] [Full Text] [Related]
14. The association of telomere maintenance and tert expression with susceptibility to human papillomavirus infection in cervical epithelium.
Wang LN; Wang L; Cheng G; Dai M; Yu Y; Teng G; Zhao J; Xu D
Cell Mol Life Sci; 2022 Jan; 79(2):110. PubMed ID: 35098380
[TBL] [Abstract] [Full Text] [Related]
15. Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical cancer Treated with Neoadjuvant Chemoradiation.
Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Characterization of Muellerian Tumors of the Urinary Tract.
Ortiz-Brüchle N; Wucherpfennig S; Rose M; Garczyk S; Bertz S; Hartmann A; Reis H; Szarvas T; Kiss A; Bremmer F; Golz R; Knüchel R; Gaisa NT
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200508
[TBL] [Abstract] [Full Text] [Related]
17. LPCAT1-tert fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth.
Oliver GR; Marcano-Bonilla S; Quist J; Tolosa EJ; Iguchi E; Swanson AA; Hoppman NL; Schwab T; Sigafoos A; Prodduturi N; Voss JS; Knight SM; Zhang J; Fadra N; Urrutia R; Zimmerman M; Egan JB; Bilyeu AG; Jen J; Veras E; Al-Safi R; Block M; Kerr S; Fernandez-Zapico ME; Schoolmeester JK; Klee EW
PLoS One; 2021; 16(5):e0250518. PubMed ID: 34033669
[TBL] [Abstract] [Full Text] [Related]
18. Integrated mutational landscape analysis of uterine leiomyosarcomas.
Choi J; Manzano A; Dong W; Bellone S; Bonazzoli E; Zammataro L; Yao X; Deshpande A; Zaidi S; Guglielmi A; Gnutti B; Nagarkatti N; Tymon-Rosario JR; Harold J; Mauricio D; Zeybek B; Menderes G; Altwerger G; Jeong K; Zhao S; Buza N; Hui P; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Ardighieri L; Bilguvar K; Quick CM; Silasi DA; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Imielinski M; Schwartz PE; Alexandrov LB; Lifton RP; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876771
[TBL] [Abstract] [Full Text] [Related]
19. Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and tert promoter mutations: A case report.
Cai JW; Chen XY; Chen JY; Wu ZY; Wu XY; Yu LH; You HH
Medicine (Baltimore); 2021 Apr; 100(13):e25346. PubMed ID: 33787635
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma.
Huang RSP; Haberberger J; Murugesan K; Danziger N; Hiemenz M; Severson E; Duncan DL; Ramkissoon SH; Ross JS; Elvin JA; Lin DI
Mod Pathol; 2021 Jul; 34(7):1425-1433. PubMed ID: 33637877
[TBL] [Abstract] [Full Text] [Related]
[Next]
